SLC5A2 and myocardial infarction: Table 6 reveals the univariate analysis showing that SGLT2 inhibitor therapy, age, male sex, GPT, LDL-C, T-CHO, and HDL-C were significant factors for myocardial infarction. The matched multivariate analysis showed that SGLT2 inhibitor therapy significantly reduced the incidence of myocardial infarction (HR: 0.47, 95% CI: 0.31–0.72, p < 0.001). In addition, HDL-C (HR: 0.63, 95% CI: 0.5–0.79, p < 0.001) significantly reduced the incidence of myocardial infarction.